Manuscripts
Showing 1554 manuscripts.
Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens
Citation
Brookie M Best, Edmund Capparelli, Jiajia Wang, David Shapiro, Nahida Chakhtoura, Mark Mirochnick, Ahizechukwu C Eke, Regis Kreitchmann, Alice Stek, IMPAACT P1026s protocol team. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens. Contraception. 2022. 105: 67-74. PMID: 34407424Year
2022
Journal
Contraception
Study
P1026S
Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk
Citation
Lubbe Wiesner, Buyisile Mkhize, Tracy Kellermann, Jennifer Norman, Sandra Castel, Anton Joubert, Kelly E. Dooley, Jyoti S. Mathad. Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk. Journal of Pharmaceutical and Biomedical Analysis. 2022. 215PMID: 35462285Year
2022
Journal
Journal of Pharmaceutical and Biomedical Analysis
Study
IMPAACT 2001
Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection
Citation
Kevin Butler, Marion G. Peters, Tichaona Vhembo, Dhayendre Moodley, Vani Govender, Neaka Mohtashemi, Hannah Ship, Philippa Musoke, Dingase Dula, Kathy George, Nahida Chakhtoura, Mary G. Fowler, Judith S. Currier, Debika Bhattacharya, Flavia Matovu Kiweewa, Camlin Tierney. Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection. Journal of AIDS. 2022. 91: 79-84. PMID: 35621877Year
2022
Journal
Journal of AIDS
Study
1077BF, 1077FF
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children
Citation
Petronella Muresan, Mariam Aziz, Matthew S. Kelly, Lijuan Yang, Elizabeth J. McFarland, Cindy Luongo, Charlotte Perlowski, Peter L. Collins, Jennifer Libous, Ursula J. Buchholz, Jennifer Oliva, IMPAACT 2018 Study Team, Patrick Jean-Philippe, Jack Moye Jr., Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Coleen K. Cunningham, Mary Paul, Ruth A. Karron, Jaime G. Deville. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/delta NS2/delta 1313/I1314L and RSV/276 in RSV-Seronegative Children. Journal of Infectious Diseases. 2022. 226: 2069-2078. PMID: 35732186Year
2022
Journal
Journal of Infectious Diseases
Study
IMPAACT 2018
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
Citation
Paula Britto, Amita Gupta, Priya Jayachandran, Kelly E Dooley, Lubbe Wiesner, IMPAACT 2001 Study Team, Grace Montepiedra, Jennifer Norman, Nan Zhang, Ellen Townley, Nahida Chakhtoura, Sarah Bradford, Sandesh Patil, Stephanie Popson, Tsungai Chipato, Vanessa Rouzier, Deborah Langat, Jyoti S Mathad, Amphan Chalermchockcharoentkit, Rada Savic, Portia Kamthunzi. Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. Clinical Infectious Diseases. 2022. 74: 1604-1613. PMID: 34323955Year
2022
Journal
Clinical Infectious Diseases
Study
IMPAACT 2001
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study
Citation
Avy Violari, IMPAACT P1106 team, Mark F. Cotton, Mae Cababasay, Jiajia Wang, Ruth Mathiba, Lubbe Wiesner, Andrew Wiznia, Pearl Samson, Renee Browning, Jack Moye, Firdose L. Nakwa, Bobbie Graham, Eric Decloedt, Helena Rabie, Adrie Bekker, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study. Lancet HIV. 2022. PMID: 27936233Year
2022
Journal
Lancet HIV
Study
P1106
Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure
Citation
Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari, Jiajia Wang, Mae Cababasay, Lubbe Wiesner, Renee Browning, Jack Moye, Edmund V. Capparelli, Radojka M. Savic, Agathe Béranger, Adrie Bekker. Influence of NAT2 genotype and maturation on isoniazid exposure in low-birth-weight and preterm infants with or without HIV exposure. Clinical Infectious Diseases. 2022. PMID: 35134861Year
2022
Journal
Clinical Infectious Diseases
Study
P1106
Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term
Citation
Esaú C João, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David Shapiro, Mark Mirochnick, Lisa M. Frenkel, Ceejay L. Boyce, Ingrid A. Beck. Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term. PLoS One. 2022. 17: e0275254. PMID: 36166463Year
2022
Journal
PLoS One
Study
P1081
Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081
Citation
Geraldo Duarte, Alice Stek, Avy Violari, Cristina B. Hofer, Jaime G. Deville, James Samwel Ngocho, José Henrique Pilotto, Mario Dias Correa Jr., David E. Shapiro, Trevon L. Fuller, Nahida Chakhtoura, Mark Mirochnick, Esaú C. João, Conrado Milani Coutinho, Meredith G. Warshaw. Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. Journal of Acquired Immune Deficiency Syndromes. 2022. 91: 403-409. PMID: 36049477Year
2022
Journal
Journal of Acquired Immune Deficiency Syndromes
Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children
Citation
Sharon Nachman, Nicole S Sampson, Xinxin Yang, Matthew F Wipperman. Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children. BMC Infectious Diseases. 2022. 22: 158. PMID: 35177035Year
2022
Journal
BMC Infectious Diseases
Study
P1041